Art's Way Scientific to build a 6,000 sq. ft. complex for prestigious cancer research center

Art's Way Manufacturing, Inc. (Nasdaq: ARTW), announces its wholly owned subsidiary, Art's Way Scientific, Inc. buildingsforscience.com will be providing design, manufacturing and installation of a 6,000 sq. ft. two story laboratory and office building for Lockard Construction, Inc. www.lockardonline.com who is the prime contractor on this complex for a well known, nationally respected cancer research center. The contract is valued at approximately $3 million.

Dan Palmer, General Manager of Art's Way Scientific said, "We are very pleased to be associated with this prestigious cancer research institute. This site will be the center of an intensive new effort to bring together nonprofit partners; working side-by-side, utilizing technological resources second to none, to more rapidly translate the latest genetic and molecular discoveries about cancer into effective new treatments that benefit cancer patients.

"This is the second project we have completed for Lockard Construction. The first project was a 9,000 sq. ft. research facility we completed in 2008."

J. Ward McConnell, Jr., Executive Chairman of the Board, said, "We are gratified to be working again with Lockard Construction on this important program. Art's Way Scientific's combined experience and performance record with this renown cancer research center is proof our contribution is critical to their mission of discovering effective new treatments."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
History of endometriosis and fibroids linked to higher long-term risk of early death